Barclays Boosts Editas Medicine (NASDAQ:EDIT) Price Target to $11 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report)’s stock price gapped up prior to trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $8.00 to $9.00. The stock had previously closed at $8.86, but opened at $10.24. JPMorgan Chase & Co. currently has a neutral rating on the […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares gapped up before the market opened on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $8.00 to $9.00. The stock had previously closed at $8.86, but opened at $10.24. JPMorgan Chase & Co. currently has a neutral rating on the […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report)’s stock price gapped up prior to trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $8.00 to $9.00. The stock had previously closed at $8.86, but opened at $10.24. JPMorgan Chase & Co. currently has a neutral rating on the […]
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Analysts at Zacks Research increased their Q1 2024 EPS estimates for shares of Editas Medicine in a research note issued on Thursday, February 15th. Zacks Research analyst A. Chakraborty now expects that the company will earn ($0.71) per share for the quarter, up from their prior estimate […]